Related Experiment Video
Updated: Apr 25, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Concerns of patients undergoing palliative chemotherapy for end-stage carcinomatous peritonitis
Mayumi Kakuta1, Fusako Kakikawa2, Misao Chida2
1Department of Nursing, The Jikei University Hospital, Minato-ku, Japan kakutama@jikei.ac.jp.
Abstract:
We sought to identify how nurses can help to alleviate the concerns of inpatients undergoing palliative chemotherapy when the treatment effects are weakening. Semistructured interviews were conducted with 8 inpatients receiving palliative chemotherapy for end-stage carcinomatous peritonitis at a university hospital. Qualitative inductive analysis of the interview data revealed 7 categories of patient concerns. Overall, patients faced many dilemmas and expressed concerns about wanting to continue chemotherapy while also thinking about discontinuing it. However, they also expressed hope, the strength of which was influenced and changed in complex ways by each treatment outcome and the severity of their physical symptoms. From these results, we suggest specific aspects of nursing care for patients with end-stage cancer who are receiving palliative chemotherapy that is becoming less effective.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chronic Pancreatitis II: Collaborative Care
Assessment: